Addressing Suboptimal Anti-VEGF Response in Neovascular AMD and DME
Jul 01, 02:50 PM
A panel of ophthalmologists discuss strategies for managing AMD and DME patients who exhibit suboptimal responses to their current anti-VEGF therapy.